T1	Participants 181 213	patients with endometrial cancer
T2	Participants 274 407	80 patients randomly assigned to laparoscopic lymphadenectomy and to abdominal lymphadenectomy in the treatment of endometrial cancer
T3	Participants 864 916	patients who had laparoscopic lymphadenectomy (SF-12
